GLP-1 Receptor Agonists Linked to Higher Remission in Ulcerative Colitis: Study
Researchers have found in a retrospective cohort study of patients with ulcerative colitis that treatment with liraglutide or semaglutide was associated with higher remission…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 26 21:30 ETSource: Medical Dialogues
From the source
Read at medicaldialogues.inGLP-1 Receptor Agonists Linked to Higher Remission in Ulcerative Colitis: Study
Researchers have found in a retrospective cohort study of patients with ulcerative colitis that treatment with liraglutide or semaglutide was associated with higher remission rates at 12 weeks compared with no GLP-1 receptor agonist use. Weight loss was not independently associated with remission, suggesting that the potential benefit may extend beyond weight reduction. The study was published in
